The Impact of Nonselective Beta-Blocker Therapy on Portal Vein Thrombosis Risk After Liver Resection in Cirrhotic Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035794

Enrollment

Registered

2025-02-17

Start date

2025-02-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I81

Interventions

Group 1: Patients under Nonselective Beta-Blocker Therapy Group 2: Patients without Nonselective Beta-Blocker Therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -aged 18 years or older -underwent a liver resection for a bening or malignant -no PVE preoperatively

Exclusion criteria

Exclusion criteria: -Patients who had a portal vein reconstruction or multivisceral resection -Known preoperative portal vein thrombosis

Design outcomes

Primary

Measure	Time frame
The occurance of a postoperative PVE within 90 days after surgery	—

Secondary

Measure	Time frame
Postoperative complications according to the Clavien-Dindo-Klassifikation Lenght of Hospital Stay Lenght of ICU Stay	—

Countries

Germany

Contacts

Public ContactSchaima Abdelhadi

Chirurgische Klinik, Universitätsmedizin Mannheim

schaima.abdelhadi@umm.de06213832225

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026